leadf
logo-loader
viewPortage Biotech
(
CSE:PBTNASDAQ:PRTG
)

Portage Biotech to begin trading its shares on the Nasdaq February 25th

Portage Biotech Inc (CSE:PBT) (NASDAQ:PRTG) CEO Dr Ian Walters tells Proactive the clinical stage immuno-oncology company is looking forward to trading its shares on the Nasdaq Stock Exchange on February 25th.

Dr Walters explains how the Toronto-based group's listing on the Nasdaq made sense, as it now has 'momentum' going into clinical data readouts from its three lead assets. He expects the listing to expand the investor base and better approach specialist investors within the biotech sector.

Quick facts: Portage Biotech

Follow
CSE:PBT

Price: - -

Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Empower Clinic’s Medi-Collective expands future locations to 33 covering BC,...

Empower Clinics CEO Steven McAuley joined Steve Darling from Proactive to shares news the company is expanding their national clinic rollout strategy and are preparing to open their next Medi-Collective" clinic in Etobicoke, Ontario on October 18th. McAuley also shared with Proactive the...

1 hour, 8 minutes ago

2 min read